# Efficacy of Accelerated Versus Standard Regiment of Hepatitis B Virus Vaccine Among Inflammatory Bowel Disease Patients

> **NCT05967650** · NA · UNKNOWN · sponsor: **Assiut University** · enrollment: 200 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **BIOLOGICAL:** standard hepatitis B vaccine
- **BIOLOGICAL:** accelerated HBV Vaccine

## Key facts

- **NCT ID:** NCT05967650
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05967650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05967650, "Efficacy of Accelerated Versus Standard Regiment of Hepatitis B Virus Vaccine Among Inflammatory Bowel Disease Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05967650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*